Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Schedules Conference Call for Monday, August 8 to Discuss Second Quarter 2005 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Monday, August 8 to Discuss Second Quarter 2005 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--July 25, 2005--Integra LifeSciences Holdings Corporation (Nasdaq: IART) has scheduled a conference
View HTML
Toggle Summary United States Supreme Court Vacates Circuit Court Decision in Integra LifeSciences -- Merck KGaA Litigation: Reasonableness Test Offered by Integra as Controlling Standard Remains Intact
United States Supreme Court Vacates Circuit Court Decision in Integra LifeSciences -- Merck KGaA Litigation: Reasonableness Test Offered by Integra as Controlling Standard Remains Intact PLAINSBORO, N.J., June 13, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today
View HTML
Toggle Summary Integra LifeSciences Announces Planned Restructuring of its European Operations
Integra LifeSciences Announces Planned Restructuring of its European Operations PLAINSBORO, N.J., June 1, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the planned reorganization of its European operations.
View HTML
Toggle Summary Integra LifeSciences Announces Results of Stockholders' Vote at Annual Meeting
Integra LifeSciences Announces Results of Stockholders' Vote at Annual Meeting PLAINSBORO, N.J., May 17, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced at the annual meeting of stockholders today that David C. Auth, Ph.D., Keith Bradley, Ph.D., Richard E.
View HTML
Toggle Summary Integra LifeSciences Reports Record Revenues for the First Quarter 2005
Integra LifeSciences Reports Record Revenues for the First Quarter 2005 PLAINSBORO, N.J., May 8, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its first quarter financial results. Total revenues in the first quarter of 2005 were $65.8 million, reflecting
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Monday, May 9 to Discuss First Quarter 2005 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Monday, May 9 to Discuss First Quarter 2005 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--April 26, 2005--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call
View HTML
Toggle Summary Integra NeuroSciences Launches New State-of-the-Art External CSF Drainage System
Integra NeuroSciences Launches New State-of-the-Art External CSF Drainage System PLAINSBORO, N.J., April 18, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will market and sell the AccuDrain™ External CSF Drainage System.
View HTML
Toggle Summary Integra NeuroSciences Launches Suturable DuraGen Dural Regeneration Matrix
Integra NeuroSciences Launches Suturable DuraGen Dural Regeneration Matrix PLAINSBORO, N.J., April 17, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced it has received 510(k) clearance from the United States Food and Drug Administration to market the
View HTML
Toggle Summary Integra LifeSciences Reports Fourth Quarter and Full Year 2004 Financial Results
Integra LifeSciences Reports Fourth Quarter and Full Year 2004 Financial Results PLAINSBORO, N.J., March 13, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its fourth quarter and full year 2004 revenues and earnings.
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Monday, March 14 to Discuss Fourth Quarter and Full Year 2004 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Monday, March 14 to Discuss Fourth Quarter and Full Year 2004 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--Feb. 25, 2005--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a
View HTML